Table 3.
Association between IBD and parenteral malignancies.
| Exposures | Outcomes | IVW |
||
|---|---|---|---|---|
| OR (95% CI) | p | Power (%) | ||
| IBD | FinnGen | |||
| Diffuse large B-cell lymphoma | 1.2450 (1.0311‒1.5034) | 0.023 | 100 | |
| UC | FinnGen | |||
| Non-melanoma skin cancer | 1.0449 (1.0030‒1.0886) | 0.035 | 100 | |
| Melanoma | 1.0280 (0.9860‒1.0718) | 0.019 | 98 | |
| Skin cancer | 0.8581 (0.6283‒1.1720) | 0.336 | ||
| UKB | ||||
| Non-melanoma skin cancer | 1.0034 (1.0015‒1.0052) | <0.001 | 8 | |
| Melanoma | 1.0003 (0.9998‒1.0008) | 0.311 | ||
| Skin cancer | 1.0004 (1.0001‒1.0006) | 0.007 | 9 | |
| CD | FinnGen | |||
| Non-melanoma skin cancer | 1.0288 (1.0023‒1.0560) | 0.034 | 99 | |
| Melanoma | 1.0004 (0.7892‒1.2680) | 0.998 | ||
| Skin cancer | 1.0287 (1.0022‒1.0559) | 0.033 | 99 | |
| UKB | ||||
| Non-melanoma skin cancer | 1.0017 (1.0001‒1.0033) | 0.033 | 6 | |
| Melanoma | 1.0004 (0.9999 ‒1.0008) | 0.076 | ||
| Skin cancer | 1.0002 (0.9999 ‒1.0005) | 0.078 | ||
IBD, Inflammatory Bowel Disease; IVW, Inverse Variance Weighted; OR, Odds Ratio, CI, Confidence Interval; UC, Ulcerative Colitis; UKB, the UK Biobank; CD, Crohn's Disease.